COMPASS Pathways Plc
Last updated September 27, 2026
Organization details
- Legal name
- COMPASS Pathways Plc
- Former names
- Compass Rx Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Chesire
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- CMPS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001816590
Board of directors
-
Annalisa Jenkins · DirectorSince 2023
-
Daphne Karydas · DirectorSince 2023
-
David Y. Norton · DirectorSince 2023
-
Ekaterina Malievskaia · DirectorSince 2023
-
George Jay Goldsmith · DirectorSince 2023
-
Gino Santini · DirectorSince 2024
-
Jeffrey M. Jonas · DirectorSince 2025
-
Justin D. Gover · DirectorSince 2025
-
Kabir Nath · Director · Chief Executive OfficerSince 2023
-
Kathleen Tregoning · DirectorSince 2026
-
Linda McGoldrick · DirectorSince 2023
-
Robert McQuade · DirectorSince 2023
-
Thomas Lonngren · DirectorSince 2023
-
Wayne Joseph Riley · DirectorSince 2023
Chief executives
Kabir Nath
· Chief Executive Officer
Dates unknown
Board connections
6 of this board's directors also sit on 10 other boards.
- via Gino Santini
- via Justin D. Gover
- via Wayne Joseph Riley
- via Wayne Joseph Riley
- via Annalisa Jenkins
- via Daphne Karydas
- via Annalisa Jenkins
- via Kathleen Tregoning
- via Annalisa Jenkins
- via Justin D. Gover
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −5,962 | $11.25 | $67,073 |
| Mar 26, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Grant or award | +175,000 | — | — |
| Mar 26, 2026 | Teri Loxam Officer (Chief Financial Officer) | Grant or award | +75,000 | — | — |
| Mar 11, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −13,131 | $6.89 | $90,473 |
| Mar 11, 2026 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −1,781 | $6.89 | $12,271 |
| Mar 2, 2026 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −4,467 | $7.02 | $31,358 |
| Feb 2, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −16,181 | $6.61 | $106,956 |
| Aug 1, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −6,366 | $4.34 | $27,628 |
| Mar 11, 2025 | Teri Loxam Officer (Chief Financial Officer) | Grant or award | +25,000 | — | — |
| Mar 11, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Grant or award | +92,000 | — | — |
| Mar 3, 2025 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −4,468 | $3.67 | $16,398 |
| Feb 3, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −15,516 | $4.31 | $66,874 |
| Oct 24, 2024 | Ekaterina Malievskaia 10% owner | Open-market sale | −776,565 | — | — |
| Oct 24, 2024 | George Jay Goldsmith 10% owner | Open-market sale | −776,565 | — | — |
| Oct 24, 2024 | Ekaterina Malievskaia 10% owner | Open-market sale | −776,565 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.